Vox Sanguinis · 2020 · 12 citations · 27 references
MedicineHematologyOncologyChemotherapyMedical OncologyTransfusion MedicineAnemiaBlood Transfusion ManagementChemotherapy In Hematologic MalignanciesRed Blood Cell TransfusionTransfusion SupportTransfusion TherapyHemoglobin-based Transfusion TriggersOncologic Transfusion SupportRed Blood Cell Transfusion LoadRed Blood Cell Transfusion ThresholdsRestrictive Transfusion ThresholdsSupportive ManagementTransfusion IndicationsTransfusion Threshold Assessment
BACKGROUND AND OBJECTIVES: Red blood cell (RBC) transfusions are needed by almost every acute myeloid leukaemia (AML) patient undergoing induction chemotherapy and constitute a cornerstone in supportive measures for cancer patients in general. Randomized controlled trials have shown non-inferiority or even superiority of restrictive transfusion guidelines over liberal transfusion guidelines in specific clinical situations outside of medical oncology. In this study, we analysed whether more restrictive RBC transfusion reduces blood use without affecting hard outcomes. MATERIALS AND METHODS: A total of 352 AML patients diagnosed between 2007 and 2018 and undergoing intensive induction chemotherapy were included in this retrospective analysis. In the less restrictive transfusion group, patients received RBC transfusion for haemoglobin levels below 8 g/dl (2007-2014). In the restrictive transfusion group, patients received RBC transfusion for haemoglobin levels below 7 g/dl (2016-2018). Liberal transfusion triggers were never endorsed. RESULTS: A total of 268 (76·1%) and 84 (23·9%) AML patients fell into the less restrictive and restrictive transfusion groups, respectively. The less restrictive transfusion group had 1 g/dl higher mean haemoglobin levels, received their first RBC transfusions earlier and needed 1·5 more units of RBC during the hospital stay of induction chemotherapy. Febrile episodes, C-reactive protein levels, admission to the intensive care unit, length of hospital stay as well as response and survival rates did not differ between the two cohorts. CONCLUSION: From our retrospective analysis, we conclude that a more restrictive transfusion trigger does not affect important outcomes of AML patients. The opportunity to test possible effects of the more severe anaemia in the restrictive transfusion group on quality of life was missed.
27
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases · 2011 · 3.4K citations
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
Càndid Villanueva, Alan Colomo, Alba Fernández Bosch et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text
Medicine, Hematology, Hemostasis +12
Bob Löwenberg, James R. Downing, Alan K. Burnett · New England Journal of Medicine · 1999 · 1.2K citations